Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer

In patients with cancer who have venous thromboembolism (VTE) events, long-term anticoagulation with low-molecular-weight heparin (LMWH) is recommended to prevent recurrent VTE. The effectiveness of a direct oral anticoagulant (DOAC) compared with LMWH for preventing recurrent VTE in patients with c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Deborah Schrag, Hajime Uno, Rachel Rosovsky, Cynthia Rutherford, Kristen M. Sanfilippo, John L. Villano, Monic Drescher, Nagesh Jayaram, Chris E. Holmes, Lawrence E. Feldman, Ottavia Zattra, Haley Farrar-Muir, Christine Cronin, Ethan Basch, Anna Weiss, Jean M. Connors, Kenneth Sumida, Robert C. Martin, Maria T. Grosse Perdekamp, Ben Yan, Donald C. Doll, Anna Ninny J. Abraham, Tzu‐Fei Wang, Ryan M. Jones, Abirami Sivapiragasm, Ellis Levine, Kamal Haider, Paula M. Rosenblatt, James W. Fleshman, William Irvin, Meghana Raghavendra, A. Dean, Michael M. Goodman, Susanna Hong, Lisa Baumann Kreuziger, I. Alex Bowman, Steve Lo, Alfonso Tafur, Anthony J. Jaslowski, Misbah Qadir, Anasuya Gunturi, Moniba Nazeef, Kelvin Raybon, Robert I. Kaplan, Astrid C. Andreescu, Dan Sotirescu, John Keech, Albert S. Malcolm, Florin D. Andreca, Vinay Shah, Andrew D. Leavitt, Benjamin T. Marchello, Daniel Flora, Douglas Weckstein, Neelesh S. Bangalore, Jessica Belmonte, Aldemar Montero, Surbhi P. Shah, Michael Constantine, Meredith Faggen, Frederick Briccetti, Christopher S. Lathan, Robert D’Agostino, Randolph B. Fenninger, Thomas Delate
Médium: Artigo
Jazyk:angličtina
Vydáno: 2023
On-line přístup:https://doi.org/10.1001/jama.2023.7843
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1001/jama.2023.7843

Podobné jednotky